Congress trading in HUM
9 members of Congress have disclosed trading HUM — 4 purchases and 10 sales worth an estimated $178,501. Most recent disclosure: Feb 10, 2026.
See who in Congress traded HUM →About Humana Inc.
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
HUM Key Statistics
HUM in plain English
- P/E ratio (41.0) — how many dollars you pay for each $1 of HUM's yearly profit. That's high, so the market expects strong growth (and you're paying up for it).
- ROE (6.28%) — how efficiently the company turns shareholders' money into profit. This is a middling level.
- Profit margin (0.82%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend yield (0.92%) — the cash payout you'd earn per year as a % of the share price, on top of any price gains.
Compare HUM with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.